Krystal Biotech, Inc. (KRYS)
285.04
+3.03
(+1.07%)
USD |
NASDAQ |
Jan 16, 16:00
286.02
+0.98
(+0.34%)
After-Hours: 07:51
Krystal Biotech EPS Diluted (Quarterly): 2.660 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| DexCom, Inc. | 0.7035 |
| CorMedix, Inc. | 1.259 |
| ADMA Biologics, Inc. | 0.1489 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 79.36M |
| Revenue (Quarterly) | 97.80M |
| Total Expenses (Quarterly) | 18.44M |
| Enterprise Value | 7.544B |
| Gross Profit Margin (Quarterly) | 94.21% |
| Profit Margin (Quarterly) | 81.15% |
| Earnings Yield | 2.34% |
| Operating Earnings Yield | 1.86% |
| Normalized Earnings Yield | 2.339 |